Charles D. Hyman’s Thermo Fisher Scientific TMO Stock Holding History

Charles D. Hyman’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.85M	Hold	3,343	–	–	0.1%	100
2024 Q1	$1.94M	Hold	3,343	–	–	0.11%	98
2023 Q4	$1.77M	Hold	3,343	–	–	0.11%	100
2023 Q3	$1.69M	Hold	3,343	–	–	0.11%	98
2023 Q2	$1.74M	Hold	3,343	–	–	0.11%	98
2023 Q1	$1.93M	Buy	3,343 +146	+5%	+$82.3K	0.13%	93
2022 Q4	$1.76M	Hold	3,197	–	–	0.12%	96
2022 Q3	$1.62M	Buy	3,197 +19	+0.6%	+$10.6K	0.12%	95
2022 Q2	$1.73M	Hold	3,178	–	–	0.13%	94
2022 Q1	$1.88M	Hold	3,178	–	–	0.12%	98
2021 Q4	$2.12M	Buy	3,178 +6	+0.2%	+$3.75K	0.13%	96
2021 Q3	$1.81M	Buy	3,172 +13	+0.4%	+$7.13K	0.13%	96
2021 Q2	$1.59M	Buy	3,159 +200	+7%	+$94.4K	0.11%	99
2021 Q1	$1.35M	Sell	2,959 -11	-0.4%	-$5.25K	0.1%	103
2020 Q4	$1.38M	Buy	2,970 +317	+12%	+$149K	0.11%	99
2020 Q3	$1.17M	Hold	2,653	–	–	0.1%	105
2020 Q2	$961K	Buy	2,653 +1,885	+245%	+$632K	0.09%	105
2020 Q1	$218K	Hold	768	–	–	0.03%	172
2019 Q4	$250K	Buy	768 +33	+4%	+$10K	0.02%	183
2019 Q3	$214K	Hold	735	–	–	0.02%	179
2019 Q2	$216K	Hold	735	–	–	0.02%	180
2019 Q1	$201K	Buy	+735	New	+$183K	0.02%	180

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles D. Hyman's TMO Position: Q2 2024 in Review

Charles D. Hyman held its Thermo Fisher Scientific (TMO) position steady in Q2 2024 at 3,343 shares worth $1.85M. The position accounts for 0.1% of the portfolio, ranked #100.

Charles D. Hyman first reported a position in TMO in Q1 2019 and has held it in 22 quarters since. The position peaked at $2.12M in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Charles D. Hyman held 3,343 shares of Thermo Fisher Scientific worth $1.85M as of Q2 2024.
Charles D. Hyman left its Thermo Fisher Scientific share count unchanged in Q2 2024.
Thermo Fisher Scientific made up 0.1% of Charles D. Hyman's portfolio in Q2 2024, its #100 holding.
Charles D. Hyman first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 22 quarters since.
Charles D. Hyman's Thermo Fisher Scientific position peaked at $2.12M in Q4 2021.
2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.